Development of DNA vaccine for infectious bursal disease

碩士 === 國立成功大學 === 生物化學研究所 === 90 === Abstract Infectious bursal disease (IBD) is a serious disease in chickens. The pathogen of the disease is infectious bursal disease virus (IBDV). When chickens are infected by IBDV, immature B-lymphocytes in the bursa of Fabricius underg...

Full description

Bibliographic Details
Main Authors: Lei Chi Kei, 李志旗
Other Authors: C. L. Wu
Format: Others
Language:en_US
Published: 2002
Online Access:http://ndltd.ncl.edu.tw/handle/07011659620835895523
id ndltd-TW-090NCKU0107002
record_format oai_dc
spelling ndltd-TW-090NCKU01070022016-06-27T16:08:45Z http://ndltd.ncl.edu.tw/handle/07011659620835895523 Development of DNA vaccine for infectious bursal disease 傳染性華氏囊病基因疫苗的研發 Lei Chi Kei 李志旗 碩士 國立成功大學 生物化學研究所 90 Abstract Infectious bursal disease (IBD) is a serious disease in chickens. The pathogen of the disease is infectious bursal disease virus (IBDV). When chickens are infected by IBDV, immature B-lymphocytes in the bursa of Fabricius undergo apoptosis, which result in immunosuppression. The prevention of IBD is vaccination. In this study, a DNA vaccine based on the VP2 protein was used to immunize chickens against IBD. The viral protein VP2 can produce neutralizing antibody. The VP2 cDNA was subcloned into pTCY, an eukaryotic expression vector, to generate pTCY-VP2 driven by the rat beta-actin promoter as a vector for vaccination. Chickens immunized with VP2 DNA vaccine induced anti-IBDV antibodies, including low-titer neutralizing antibody. However, these chickens died when challenged with virulent IBDV, indicating that the immunization scheme should be modified. In the results from the experiments involving the expression of VP2-EGFP in chicken embryo fibroblasts or in E. coli, we found two interesting phenomena. First there was different localization of EGFP in cells when N-terminally fused with different fragments of VP2. The green fluorescence was localized exclusively in the cytoplasm in cells transfected with pTCY-VP2-EGFP-hl, whereas the fluorescence distributed in both the cytoplasm and nucleus in cells transfected with pTCY-VP2-EGFP-fl or EGFP. The reason for discrepancy in the localization of different EGFP fusion protein is unclear. Secondly, we found that there was a ribosomal binding site at the 5’ end of the EGFP gene and a GTG codon which many serve as a translational intiation site. These sequences may interfere the translation of the VP2-EGFP fusion protein, which resulted in the difficulty in producing VP2-EGFP fusion protein. C. L. Wu 吳昭良 2002 學位論文 ; thesis 46 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 國立成功大學 === 生物化學研究所 === 90 === Abstract Infectious bursal disease (IBD) is a serious disease in chickens. The pathogen of the disease is infectious bursal disease virus (IBDV). When chickens are infected by IBDV, immature B-lymphocytes in the bursa of Fabricius undergo apoptosis, which result in immunosuppression. The prevention of IBD is vaccination. In this study, a DNA vaccine based on the VP2 protein was used to immunize chickens against IBD. The viral protein VP2 can produce neutralizing antibody. The VP2 cDNA was subcloned into pTCY, an eukaryotic expression vector, to generate pTCY-VP2 driven by the rat beta-actin promoter as a vector for vaccination. Chickens immunized with VP2 DNA vaccine induced anti-IBDV antibodies, including low-titer neutralizing antibody. However, these chickens died when challenged with virulent IBDV, indicating that the immunization scheme should be modified. In the results from the experiments involving the expression of VP2-EGFP in chicken embryo fibroblasts or in E. coli, we found two interesting phenomena. First there was different localization of EGFP in cells when N-terminally fused with different fragments of VP2. The green fluorescence was localized exclusively in the cytoplasm in cells transfected with pTCY-VP2-EGFP-hl, whereas the fluorescence distributed in both the cytoplasm and nucleus in cells transfected with pTCY-VP2-EGFP-fl or EGFP. The reason for discrepancy in the localization of different EGFP fusion protein is unclear. Secondly, we found that there was a ribosomal binding site at the 5’ end of the EGFP gene and a GTG codon which many serve as a translational intiation site. These sequences may interfere the translation of the VP2-EGFP fusion protein, which resulted in the difficulty in producing VP2-EGFP fusion protein.
author2 C. L. Wu
author_facet C. L. Wu
Lei Chi Kei
李志旗
author Lei Chi Kei
李志旗
spellingShingle Lei Chi Kei
李志旗
Development of DNA vaccine for infectious bursal disease
author_sort Lei Chi Kei
title Development of DNA vaccine for infectious bursal disease
title_short Development of DNA vaccine for infectious bursal disease
title_full Development of DNA vaccine for infectious bursal disease
title_fullStr Development of DNA vaccine for infectious bursal disease
title_full_unstemmed Development of DNA vaccine for infectious bursal disease
title_sort development of dna vaccine for infectious bursal disease
publishDate 2002
url http://ndltd.ncl.edu.tw/handle/07011659620835895523
work_keys_str_mv AT leichikei developmentofdnavaccineforinfectiousbursaldisease
AT lǐzhìqí developmentofdnavaccineforinfectiousbursaldisease
AT leichikei chuánrǎnxìnghuáshìnángbìngjīyīnyìmiáodeyánfā
AT lǐzhìqí chuánrǎnxìnghuáshìnángbìngjīyīnyìmiáodeyánfā
_version_ 1718323940975181824